Falkman L.; Sundin A.; Skogseid B.; Botling J.; Bernardo Y.; Wallin G.; Zhang L.; Welin S.; Lase I.; Mollazadegan K.; Crona J. Genetics-Guided Therapy in Neuroendocrine Carcinoma: Response to BRAF- and MEK-Inhibitors. ujms 2024, 129, e10660.